Filing Details
- Accession Number:
- 0001683168-21-006646
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-29 19:23:40
- Reporting Period:
- 2021-12-27
- Accepted Time:
- 2021-12-29 19:23:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
704562 | Avid Bioservices Inc. | CDMO | Pharmaceutical Preparations (2834) | 953698422 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1552642 | R Mark Ziebell | 2642 Michelle Drive, Suite 200 Tustin CA 92780 | V. P., General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Disposition | 2021-12-27 | 6,829 | $30.27 | 7,429 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 14, 2021.
- Represents a weighted average sales price per share. These shares were sold at prices ranging from $30.04 to $30.54. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.